GleamWall
中文EN

STME Stimcell Energetics Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1493712 · Fiscal year ends 05/31

Financial factors as of 2026-08-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-4.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-2,067.1%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets3,334.9%
Debt / equity—
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.39x
Accruals ratio-1,257.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY2026*2026-05-31FY2025*2025-05-31
Income statement
Revenue——
SG&A expense$382,560$213,452
Interest expense$69,348$38,256
Net income-$895,375-$566,293
EPS (basic)-0.04-0.03
EPS (diluted)——
Balance sheet
Cash & equivalents$3,057$14,581
Total assets$81,454$21,222
Total liabilities$1.89M$1.27M
Shareholders' equity-$1.81M-$1.25M
Cash flow statement
Operating cash flow-$312,081-$141,600
Financing cash flow$300,582$112,858

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.